Savient Pharmaceuticals Inc (NASDAQ:SVNT)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar pchop123 (76.62) Submitted: 11/9/2012 5:28:19 PM : Underperform Start Price: $1.18 SVNT Score: +5.39

down & down

Featured Broker Partners


Advertisement